155 related articles for article (PubMed ID: 3486248)
1. Viruses disrupt functions of human lymphocytes. II. Measles virus suppresses antibody production by acting on B lymphocytes.
McChesney MB; Fujinami RS; Lampert PW; Oldstone MB
J Exp Med; 1986 May; 163(5):1331-6. PubMed ID: 3486248
[TBL] [Abstract][Full Text] [Related]
2. Viruses disrupt functions of human lymphocytes. Effects of measles virus and influenza virus on lymphocyte-mediated killing and antibody production.
Casali P; Rice GP; Oldstone MB
J Exp Med; 1984 May; 159(5):1322-37. PubMed ID: 6716049
[TBL] [Abstract][Full Text] [Related]
3. The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system.
Nakagawa N; Nakagawa T; Volkman DJ; Ambrus JL; Fauci AS
J Immunol; 1987 Feb; 138(3):795-801. PubMed ID: 3100616
[TBL] [Abstract][Full Text] [Related]
4. Regulation of B cell maturation and differentiation. I. Suppression of pokeweed mitogen-induced B cell differentiation by tumor necrosis factor (TNF).
Kashiwa H; Wright SC; Bonavida B
J Immunol; 1987 Mar; 138(5):1383-90. PubMed ID: 2949015
[TBL] [Abstract][Full Text] [Related]
5. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
[TBL] [Abstract][Full Text] [Related]
6. Selective immunosuppressive effects of measles virus infection.
Pelton BK; Hylton W; Denman AM
Clin Exp Immunol; 1982 Jan; 47(1):19-26. PubMed ID: 6284422
[TBL] [Abstract][Full Text] [Related]
7. Production of BSF-1 during an in vivo, T-dependent immune response.
Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
[TBL] [Abstract][Full Text] [Related]
8. Modulation of immune system function by measles virus infection. II. Infection of B cells leads to the production of a soluble factor that arrests uninfected B cells in G0/G1.
Wang M; Libbey JE; Tsunoda I; Fujinami RS
Viral Immunol; 2003; 16(1):45-55. PubMed ID: 12725688
[TBL] [Abstract][Full Text] [Related]
9. Measles immune suppression: lessons from the macaque model.
de Vries RD; McQuaid S; van Amerongen G; Yüksel S; Verburgh RJ; Osterhaus AD; Duprex WP; de Swart RL
PLoS Pathog; 2012; 8(8):e1002885. PubMed ID: 22952446
[TBL] [Abstract][Full Text] [Related]
10. The effect of measles virus infection on T and B lymphocytes in the mouse. I. Suppression of helper cell activity.
McFarland HF
J Immunol; 1974 Dec; 113(6):1978-83. PubMed ID: 4139203
[No Abstract] [Full Text] [Related]
11. Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE.
Kreth WH; Käckell MY; ter Meulen V
J Immunol; 1975 Mar; 114(3):1042-6. PubMed ID: 1089723
[TBL] [Abstract][Full Text] [Related]
12. CD4 T cell control primary measles virus infection of the CNS: regulation is dependent on combined activity with either CD8 T cells or with B cells: CD4, CD8 or B cells alone are ineffective.
Tishon A; Lewicki H; Andaya A; McGavern D; Martin L; Oldstone MB
Virology; 2006 Mar; 347(1):234-45. PubMed ID: 16529787
[TBL] [Abstract][Full Text] [Related]
13. Human peripheral blood monocytes release a 30,000 dalton factor (30 KD MF) that stimulates immunoglobulin production by activated B cells.
Rossen RD; Laughter AH; Orson FM; Flagge FP; Cashaw JL; Sumaya CV
J Immunol; 1985 Nov; 135(5):3289-97. PubMed ID: 3930602
[TBL] [Abstract][Full Text] [Related]
14. Specific and non-specific B cell activation in measles and varicella.
Arneborn P; Biberfeld G; Forsgren M; von Stedingk LV
Clin Exp Immunol; 1983 Jan; 51(1):165-72. PubMed ID: 6299636
[TBL] [Abstract][Full Text] [Related]
15. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.
Petersen J
Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810
[TBL] [Abstract][Full Text] [Related]
16. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608
[TBL] [Abstract][Full Text] [Related]
17.
Laksono BM; Grosserichter-Wagener C; de Vries RD; Langeveld SAG; Brem MD; van Dongen JJM; Katsikis PD; Koopmans MPG; van Zelm MC; de Swart RL
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437964
[TBL] [Abstract][Full Text] [Related]
18. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
Shimizu K; Hirano T; Ishibashi K; Nakano N; Taga T; Sugamura K; Yamamura Y; Kishimoto T
J Immunol; 1985 Mar; 134(3):1728-33. PubMed ID: 2981920
[TBL] [Abstract][Full Text] [Related]
19. Effect of measles virus infection on MHC class II expression and antigen presentation in human monocytes.
Leopardi R; Ilonen J; Mattila L; Salmi AA
Cell Immunol; 1993 Apr; 147(2):388-96. PubMed ID: 7680965
[TBL] [Abstract][Full Text] [Related]
20. Human T cell leukemia/lymphoma virus-infected antigen-specific T cell clones: indiscriminant helper function and lymphokine production.
Volkman DJ; Popovic M; Gallo RC; Fauci AS
J Immunol; 1985 Jun; 134(6):4237-43. PubMed ID: 2580910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
